Combination Chemotherapy of Azacitidine and Cetuximab for Therapy-Related Acute Myeloid Leukemia following Oxaliplatin for Metastatic Colorectal Cancer
Therapy-related leukemia (TRL) has been reported to occur after treatment with alkylating agents and/or topoisomerase II inhibitors. Oxaliplatin (OXP) is used as a key drug for the treatment of colorectal cancer (CRC). Cisplatin and carboplatin have been linked with TRL, but the involvement of OXP i...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
S. Karger AG
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049016/ |